DCB vs DES, Where is the Limit?

Published: 13 February 2023

  • Views:

    Views Icon 2764
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


Drug-coated balloon (DCB) technology permits effective delivery of a drug to a lesion in the arterial wall, but not all DCBs are the same. The Essential pro DCB from iVascular has premium deliverability and last generation nanotechnology TransferTech, proving its reliability.
In this series of insightful presentations and discussions, moderator Prof Jose M de la Torre (Cantabria, ES) is joined by Dr Lucio Padilla (Buenos Aires, AR) and Dr Adam Sukiennik (Toruń, PL) to discuss the application and effectiveness of drug-coated balloons vs drug-eluting stents. They highlight the key benefits given by Essential pro and present several clinical cases where its efficacy has been demonstrated.
The faculty explore unique components of DCB technology and mechanism of action, explaining in detail the key differentiation between Essential pro and other DCBs, in addition to providing insight into Essential pro application in challenging cases, including bifurcations.

This video series is supported by

Learning Objectives

  • When to use a DCB
  • What is important when using a DCB
  • Benefits of using Essential pro

Target Audience

  • Interventional Cardiologists

More from this programme

Part 1

DCB vs DES, Where is the limit? Full Length Video

Part 2

The DCB’s Technology Makes the Difference

Part 4

DCBs for Provisional Stenting in Bifurcations

Part 5

Benefits of DCBs for HBR Patients

Part 6

The Advantages of a DCB

About the episode

Prof Jose M de la Torre (Cantabria, ES) delves into the significant benefits of using DCBs in treating patients with high bleeding risk (HBR) and highlights this through two clinical cases. Prof de la Torre has a lot of experience with Essential pro, which has always demonstrated very good results for HBR patients.

Faculty Biographies

José M de la Torre Hernández

José M de la Torre Hernández

Head of Hemodynamics and Interventional Cardiology

Prof Jose M de la Torre is an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, ES.

Prof Jose M de la Torre is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting in US. Faculty of ESC, PCR, ACC and TCT meetings. Coordinator of the ESTROFA, XIMA and LITRO study groups. 


View full profile


You must be to comment. If you are not registered, you can register here.